Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Effects of geranylgeranyltransferaseⅠsilencing on the proliferation of tongue squamous cancer cells].
Ying W, Qimin W, Jinghua L, Jinhong H, Lili W, Chen C, Jianhua Z, Lei T, Xufei L, Yuan Z, Yixiang L, Zongxuan H, Ning L, Lei C, Wenjun L, Zhenggang C. Ying W, et al. Among authors: jinghua l. Hua Xi Kou Qiang Yi Xue Za Zhi. 2017 Aug 1;35(4):373-378. doi: 10.7518/hxkq.2017.04.006. Hua Xi Kou Qiang Yi Xue Za Zhi. 2017. PMID: 28853502 Free PMC article. Chinese.
Correction to: Clinical prospective study of Gallium 68 (68Ga)-labeled fibroblast‑activation protein inhibitor PET/CT in the diagnosis of biliary tract carcinoma.
Jinghua L, Kui X, Deliang G, Bo L, Qian Z, Haitao W, Yaqun J, Dongde W, Xigang X, Ping J, Shengli T, Zhiyong Y, Yueming H, Zhonglin Z, Yong H, Yufeng Y. Jinghua L, et al. Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):2230. doi: 10.1007/s00259-023-06188-2. Eur J Nucl Med Mol Imaging. 2023. PMID: 36929212 No abstract available.
Clinical prospective study of Gallium 68 (68Ga)-labeled fibroblast-activation protein inhibitor PET/CT in the diagnosis of biliary tract carcinoma.
Jinghua L, Kui X, Deliang G, Bo L, Qian Z, Haitao W, Yaqun J, Dongde W, Xigang X, Ping J, Shengli T, Zhiyong Y, Yueming H, Zhonglin Z, Yong H, Yufeng Y. Jinghua L, et al. Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):2152-2166. doi: 10.1007/s00259-023-06137-z. Epub 2023 Feb 21. Eur J Nucl Med Mol Imaging. 2023. PMID: 36809426
Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
Bi Y, Gao R, Patel A, Su S, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Turnbull F; CPACS Investigators. Bi Y, et al. Am Heart J. 2009 Mar;157(3):509-516.e1. doi: 10.1016/j.ahj.2008.09.026. Epub 2008 Dec 17. Am Heart J. 2009. PMID: 19249422